Dynamic expression of HOPX in alveolar epithelial cells reflects injury and repair during the progression of pulmonary fibrosis

Scientific Reports

Volumn 8, Issue 1, 2018, Pages

  Ota, Chiharu ^a,b   Ng Blichfeldt, John Poul ^c   Korfei, Martina ^d   Alsafadi, Hani N ^a   Lehmann, Mareike ^a   Skronska Wasek, Wioletta ^a   M De Santis, Martina ^a   Guenther, Andreas ^d   Wagner, Darcy E ^a,e   Königshoff, Melanie ^a,f  

^a UNIVERSITY OF MUNICH   (Germany)

^b TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d JUSTUS LIEBIG UNIVERSITY GIESSEN   (Germany)

^e LUND UNIVERSITY   (Sweden)

^f UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; HOD PROTEIN, MOUSE; HOMEODOMAIN PROTEIN; HOP PROTEIN, HUMAN; SFTPC PROTEIN, MOUSE; SIGNAL PEPTIDE; SMALL INTERFERING RNA; TUMOR SUPPRESSOR PROTEIN;

ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL LINE; CELL TRANSDIFFERENTIATION; DISEASE EXACERBATION; DISEASE MODEL; FEMALE; FIBROSING ALVEOLITIS; GENETIC TRANSFECTION; GENETICS; HUMAN; LUNG; LUNG ALVEOLUS; LUNG ALVEOLUS EPITHELIUM CELL; LUNG FIBROSIS; METABOLISM; MOUSE; PATHOLOGY; PHYSIOLOGY; REGENERATION; RNA INTERFERENCE;

ALVEOLAR EPITHELIAL CELLS; ANIMALS; BLEOMYCIN; CELL LINE; CELL TRANSDIFFERENTIATION; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FEMALE; HOMEODOMAIN PROTEINS; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LUNG; MICE; MICE, INBRED C57BL; PULMONARY ALVEOLI; PULMONARY FIBROSIS; REGENERATION; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRANSFECTION; TUMOR SUPPRESSOR PROTEINS;

EID: 85052401221     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-018-31214-x     Document Type: Article

References (50)

1. Knudsen, L., Ruppert, C. & Ochs, M. Tissue remodelling in pulmonary fibrosis. Cell Tissue Res 367, 607–626 (2017).
2. Williams, M. C. Alveolar type I cells: molecular phenotype and development. Annu Rev Physiol 65, 669–695 (2003).
3. Ward, H. E. & Nicholas, T. E. Alveolar type I and type II cells. Aust N Z J Med 14, 731–734 (1984).
4. Kuroki, Y. & Voelker, D. R. Pulmonary surfactant proteins. J Biol Chem 269, 25943–25946 (1994).
5. Fehrenbach, H. Alveolar epithelial type II cell: defender of the alveolus revisited. Respir Res 2, 33–46 (2001).
6. Barkauskas, C. E. et al. Type 2 alveolar cells are stem cells in adult lung. J Clin Invest 123, 3025–3036 (2013).
7. Shin, C. H. et al. Modulation of cardiac growth and development by HOP, an unusual homeodomain protein. Cell 110, 725–735 (2002).
8. Chen, F. et al. Hop is an unusual homeobox gene that modulates cardiac development. Cell 110, 713–723 (2002).
9. Yin, Z. et al. Hop functions downstream of Nkx2.1 and GATA6 to mediate HDAC-dependent negative regulation of pulmonary gene expression. Am J Physiol Lung Cell Mol Physiol 291, L191–199 (2006).
10. Liebler, J. M. et al. Combinations of differentiation markers distinguish subpopulations of alveolar epithelial cells in adult lung. Am J Physiol Lung Cell Mol Physiol 310, L114–120 (2016).
11. Jain, R. et al. Plasticity of Hopx(+) type I alveolar cells to regenerate type II cells in the lung. Nat Commun 6, 6727, 10.1038/ncomms7727 (2015).
12. Takeda, N. et al. Interconversion between intestinal stem cell populations in distinct niches. Science 334, 1420–1424 (2011).
13. Takeda, N. et al. Hopx expression defines a subset of multipotent hair follicle stem cells and a progenitor population primed to give rise to K6+niche cells. Development 140, 1655–1664 (2013).
14. Cheung, W. K. et al. Control of alveolar differentiation by the lineage transcription factors GATA6 and HOPX inhibits lung adenocarcinoma metastasis. Cancer Cell 23, 725–738 (2013).
15. Pacheco-Pinedo, E. C. et al. Wnt/beta-catenin signaling accelerates mouse lung tumorigenesis by imposing an embryonic distal progenitor phenotype on lung epithelium. J Clin Invest 121, 1935–1945 (2011).
16. Mutze, K., Vierkotten, S., Milosevic, J., Eickelberg, O. & Konigshoff, M. Enolase 1 (ENO1) and protein disulfide-isomerase associated 3 (PDIA3) regulate Wnt/beta-catenin-driven trans-differentiation of murine alveolar epithelial cells. Dis Model Mech 8, 877–890 (2015).
17. Flozak, A. S. et al. Beta-catenin/T-cell factor signaling is activated during lung injury and promotes the survival and migration of alveolar epithelial cells. J Biol Chem 285, 3157–3167 (2010).
18. Demaio, L. et al. Characterization of mouse alveolar epithelial cell monolayers. Am J Physiol Lung Cell Mol Physiol 296, L1051–1058 (2009).
19. Bauer, Y. et al. MMP-7 is a predictive biomarker of disease progression in patients with idiopathic pulmonary fibrosis. ERJ Open Res 3, 10.1183/23120541.00074-2016 (2017).
20. Lehmann, M. et al. Senolytic drugs target alveolar epithelial cell function and attenuate experimental lung fibrosis ex vivo. Eur Respir J 50 (2017).
21. Xu, Y. et al. Single-cell RNA sequencing identifies diverse roles of epithelial cells in idiopathic pulmonary fibrosis. JCI Insight 1, e90558 (2016).
22. Drakopanagiotakis, F., Wujak, L., Wygrecka, M. & Markart, P. Biomarkers in idiopathic pulmonary fibrosis. Matrix Biol 68-69, 404–421 (2018).
23. Takahashi, H. et al. Monitoring markers of disease activity for interstitial lung diseases with serum surfactant proteins A and D. Respirology 11(Suppl), S51–54 (2006).
24. Collard, H. R. et al. Plasma biomarker profiles in acute exacerbation of idiopathic pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 299, L3–7 (2010).
25. Wang, K., Ju, Q., Cao, J., Tang, W. & Zhang, J. Impact of serum SP-A and SP-D levels on comparison and prognosis of idiopathic pulmonary fibrosis: A systematic review and meta-analysis. Medicine (Baltimore) 96, e7083 (2017).
26. Rosas, I. O. et al. MMP1 and MMP7 as potential peripheral blood biomarkers in idiopathic pulmonary fibrosis. PLoS Med 5, e93 (2008).
27. Ask, K. et al. Progressive pulmonary fibrosis is mediated by TGF-beta isoform 1 but not TGF-beta3. Int J Biochem Cell Biol 40, 484–495 (2008).
28. Alsafadi, H. N. et al. An ex vivo model to induce early fibrosis-like changes in human precision-cut lung slices. Am J Physiol Lung Cell Mol Physiol 312, L896–L902 (2017).
29. Desai, T. J., Brownfield, D. G. & Krasnow, M. A. Alveolar progenitor and stem cells in lung development, renewal and cancer. Nature 507, 190–194 (2014).
30. Zacharias, W. J. et al. Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor. Nature 555, 251–255 (2018).
31. Ren, X. et al. HOPX hypermethylation promotes metastasis via activating SNAIL transcription in nasopharyngeal carcinoma. Nat Commun 8, 14053, 10.1038/ncomms14053 (2017).
32. Kikuchi, M. et al. Epigenetic silencing of HOPX contributes to cancer aggressiveness in breast cancer. Cancer Lett 384, 70–78 (2017).
33. Yap, L. F. et al. HOPX functions as a tumour suppressor in head and neck cancer. Sci Rep 6, 38758, 10.1038/srep38758 (2016).
34. Yamashita, K., Katoh, H. & Watanabe, M. The homeobox only protein homeobox (HOPX) and colorectal cancer. Int J Mol Sci 14, 23231–23243 (2013).
35. Konishi, K. et al. Gene expression profiles of acute exacerbations of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 180, 167–175 (2009).
36. Seibold, M. A. et al. A common MUC5B promoter polymorphism and pulmonary fibrosis. N Engl J Med 364, 1503–1512 (2011).
37. Nogee, L. M. et al. A mutation in the surfactant protein C gene associated with familial interstitial lung disease. N Engl J Med 344, 573–579 (2001).
38. Lawson, W. E. et al. Genetic mutations in surfactant protein C are a rare cause of sporadic cases of IPF. Thorax 59, 977–980 (2004).
39. Tsakiri, K. D. et al. Adult-onset pulmonary fibrosis caused by mutations in telomerase. Proc Natl Acad Sci USA 104, 7552–7557 (2007).
40. Yang, I. V. et al. Relationship of DNA methylation and gene expression in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 190, 1263–1272 (2014).
41. Huang, S. K., Scruggs, A. M., McEachin, R. C., White, E. S. & Peters-Golden, M. Lung fibroblasts from patients with idiopathic pulmonary fibrosis exhibit genome-wide differences in DNA methylation compared to fibroblasts from nonfibrotic lung. PLoS One 9, e107055 (2014).
42. Barbas-Filho, J. V. et al. Evidence of type II pneumocyte apoptosis in the pathogenesis of idiopathic pulmonary fibrosis (IFP)/usual interstitial pneumonia (UIP). J Clin Pathol 54, 132–138 (2001).
43. Korfei, M. et al. Epithelial endoplasmic reticulum stress and apoptosis in sporadic idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 178, 838–846 (2008).
44. Bolanos, A. L. et al. Role of Sonic Hedgehog in idiopathic pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 303, L978–990 (2012).
45. Jenkins, R. G. et al. Ligation of protease-activated receptor 1 enhances alpha(v)beta6 integrin-dependent TGF-beta activation and promotes acute lung injury. J Clin Invest 116, 1606–1614 (2006).
46. Konigshoff, M. et al. WNT1-inducible signaling protein-1 mediates pulmonary fibrosis in mice and is upregulated in humans with idiopathic pulmonary fibrosis. J Clin Invest 119, 772–787 (2009).
47. Korfei, M. et al. Comparative proteomic analysis of lung tissue from patients with idiopathic pulmonary fibrosis (IPF) and lung transplant donor lungs. J Proteome Res 10, 2185–2205 (2011).
48. American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med 161, 646–664 (2000).
49. Ota, C. et al. Histone deacetylase inhibitor restores surfactant protein-C expression in alveolar-epithelial type II cells and attenuates bleomycin-induced pulmonary fibrosis in vivo. Exp Lung Res 41, 422–434 (2015).
50. Uhl, F. E. et al. Preclinical validation and imaging of Wnt-induced repair in human 3D lung tissue cultures. Eur Respir J 46, 1150–1166 (2015).